Leehee Navon-Perry

Leehee is the Director of Medical Writing (MW) at Prilenia, responsible for the preparation of regulatory and medical documents, including core submission documents.

Before joining Prilenia, Leehee was Associate Director in the Global Regulatory Medical Writing department within Global Specialty R&D at Teva Pharmaceutical Industries Ltd, where she worked for over 11 years. Throughout her tenure there, Leehee led Medical Writing for various projects (including pridopidine), as well as several therapeutic areas (CNS & movement disorders, biosimilars, immunology and psychiatry). She brings vast experience with a wide variety of document types including clinical protocols and study reports, Investigator’s Brochures, safety update reports, briefing books, responses to health authority queries as well as NDA and MAA submissions.

Leehee holds an MSc in Cell Research and Immunology from Tel Aviv University, where she also did her PhD studies in Biochemistry, as well as a BSc in biology from the Hebrew University in Jerusalem. She is an alumnus of the first cohort of the BioDesign Israel Innovation Program, a medical entrepreneurship training program in collaboration with the Stanford Faculty of Medicine and the Rambam Medical Center in Haifa.